| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/14/2011 | WO2011041938A1 Composition comprising benzoic acid in combination with organic acid preservatives as active components and use thereof |
| 04/14/2011 | WO2011041937A1 Use of hydroxytyrosol for improving muscle differentiation |
| 04/14/2011 | WO2011041914A1 Use of flubendazole and vinca alkaloids for treatment of hematological diseases |
| 04/14/2011 | WO2011041907A1 Derivatives of di(phenylpropanoid) glycerol for the treatment of cancer |
| 04/14/2011 | WO2011041894A1 Siglec 15 antibodies in treating bone loss-related disease |
| 04/14/2011 | WO2011041872A1 Nitric oxide amino acid ester compounds for the prophylaxis of angina pectoris |
| 04/14/2011 | WO2011041870A1 Non-steroidal anti-inflammatory drugs coadministered with nitric oxide amino acid ester compounds as prophylaxis in hypertensive patients |
| 04/14/2011 | WO2011041839A1 Udp-galactopyranose mutase from haemonchus contortus, and rnai agents that inhibit it |
| 04/14/2011 | WO2011026234A8 Clarithromycin extended-release tablet |
| 04/14/2011 | WO2011021203A3 Desferrioxamine-metal complexes for the treatment of immune-related disorders |
| 04/14/2011 | WO2011020023A3 Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus |
| 04/14/2011 | WO2011018798A3 Morpholino-based antisense agent |
| 04/14/2011 | WO2011017634A8 Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase |
| 04/14/2011 | WO2011016050A3 Novel compounds as modulators of glucocorticoid receptors |
| 04/14/2011 | WO2011015936A3 An improved process for the preparation of pure paliperidone |
| 04/14/2011 | WO2011002298A3 Animal feed or human food for improving intestinal barrier properties |
| 04/14/2011 | WO2011002161A3 Transdermal composition comprising tolterodine |
| 04/14/2011 | WO2010146179A3 Solid pharmaceutical composition comprising rivaroxaban |
| 04/14/2011 | WO2010143919A3 Method and composition for preventing or treating il-6-mediated diseases or rhinovirus infections |
| 04/14/2011 | WO2010142766A3 Pyrimidine derivatives as zap-70 inhibitors |
| 04/14/2011 | WO2010137979A3 Combination of a leucine source and an omega- 3 unsaturated fatty acid source for use in the treatment of hypercaemia |
| 04/14/2011 | WO2010137855A3 Multi-layer tablet comprising effervescent layer |
| 04/14/2011 | WO2010134790A3 Anti-inflammatory composition containing macrolactin a and a derivative thereof as active ingredients |
| 04/14/2011 | WO2010126260A3 Pharmaceutical composition for promoting the healing of wounds and containing lysophosphatidic acid and an adenylyl cyclase inhibitor as active ingredients |
| 04/14/2011 | WO2010120649A3 Composition and use of n-alpha-methylhistamine dihydrochloride for the reduction of oxygen radical formation |
| 04/14/2011 | WO2010094806A3 Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes |
| 04/14/2011 | WO2010093873A3 Drug delivery through hydrogel plugs |
| 04/14/2011 | WO2010081204A3 Polyamine activators ( s permine, s permidine) of the autophagic pathway |
| 04/14/2011 | WO2010060635A3 Solid pharmaceutical composition comprising at least one stabilizing agent |
| 04/14/2011 | WO2010041256A3 A composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same |
| 04/14/2011 | WO2010031832A9 Synergistic combinations of a macrocyclic inhibitor of hcv and a thiophene-2-carboxylic acid derivative |
| 04/14/2011 | WO2010027502A9 Method of inducing an anti-viral immune response |
| 04/14/2011 | WO2010012733A9 Use of a cdk inhibitor for the treatment of glioma |
| 04/14/2011 | WO2009126705A8 Induction of tumor hypoxia for cancer therapy |
| 04/14/2011 | WO2008031501A3 2-phenoxy nicotine acid derivative and use thereof |
| 04/14/2011 | US20110088106 Compositions and methods for mediating cell cycle progression |
| 04/14/2011 | US20110087192 Transmucosal drug delivery device and method including chemical permeation enhancers |
| 04/14/2011 | US20110087158 Apparatus having a fibrous skin-contactable element containing an agent |
| 04/14/2011 | US20110087153 Transdermal Methods And Systems For The Delivery Of Rizatriptan |
| 04/14/2011 | US20110087152 Fluidic tissue augmentation compositions and methods |
| 04/14/2011 | US20110087025 Method for producing 3-amidinophenylalanine derivatives |
| 04/14/2011 | US20110086923 Method to increase oxygen in male and female sexual organs through the topical use of perfluorocarbons |
| 04/14/2011 | US20110086922 Sensory-specific local anesthesia and prolonged duration local anesthesia |
| 04/14/2011 | US20110086921 Novel Polymorphic Forms of (4--2-Methylphenyl)Carbonyl]Amino}-3-Methylphenyl)Acetic Acid |
| 04/14/2011 | US20110086920 Gamma Glutamylcysteine Treatment or Prevention of Oxidative Injury |
| 04/14/2011 | US20110086919 High eicosapentaenoic acid producing strains of yarrowia lipolytica |
| 04/14/2011 | US20110086917 Use of l-carnitine for the treatment of cardiovascular diesases |
| 04/14/2011 | US20110086916 Interval therapy for the treatment of tinnitus |
| 04/14/2011 | US20110086915 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 04/14/2011 | US20110086914 Methods for Treating Traumatic Brain Injury |
| 04/14/2011 | US20110086913 Methods for treating myofascial, muscle, and/or back pain |
| 04/14/2011 | US20110086912 Derivatives of Propane Diyl Dicinnamate |
| 04/14/2011 | US20110086911 Novel bismuth(iii) nsaid compounds and methods for their use |
| 04/14/2011 | US20110086910 Method of treating or preventing pain |
| 04/14/2011 | US20110086909 Synthesis of fr901464 and analogs with antitumor activity |
| 04/14/2011 | US20110086908 Use of phosphatase inhibitors for the treatment of neurodegenerative diseases |
| 04/14/2011 | US20110086907 Acne treatment |
| 04/14/2011 | US20110086906 Methods for treatment or prevention of diseases associated with functional disorder of regulatory t cells |
| 04/14/2011 | US20110086904 GENERATION OF HYPERSTABLE mRNAs |
| 04/14/2011 | US20110086903 Emergence of a r-type ca2+ channel (cav 2.3) contributes to cerebral artery constriction following subarachnoid hemorrhage |
| 04/14/2011 | US20110086902 Compounds for the modulation of beta-catenin expression |
| 04/14/2011 | US20110086901 Oligonucleotides affecting expression of phosphodiesterases |
| 04/14/2011 | US20110086900 Compositions for prevention/prophylactic treatment of poison ivy dermatitis |
| 04/14/2011 | US20110086899 Pharmaceutical compositions for oral administration |
| 04/14/2011 | US20110086898 Pyrazolooxazole compound |
| 04/14/2011 | US20110086897 (E)-N-(2-Amino-phenyl)-3--acrylamide salts |
| 04/14/2011 | US20110086896 Crystalline and Stable Form of Andolast |
| 04/14/2011 | US20110086895 Thiazolidinedione energy restriction-mimetic agents |
| 04/14/2011 | US20110086894 Biomarkers for the diagnosis of als |
| 04/14/2011 | US20110086893 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/14/2011 | US20110086892 Pre-Mixed, Ready-To-Use Pharmaceutical Compositions |
| 04/14/2011 | US20110086891 Solid Forms of 2-(2,4-Difluorophenyl)-6-(1-(2,6-Difluorophenyl)Ureido)Nicotinamide) |
| 04/14/2011 | US20110086890 Liquid pest control formulation |
| 04/14/2011 | US20110086889 Tetrazole compounds as orexin receptor antagonists |
| 04/14/2011 | US20110086885 Indole-2-carboxylic acid amides |
| 04/14/2011 | US20110086884 Barium salt of benzimidazole derivative |
| 04/14/2011 | US20110086883 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/14/2011 | US20110086882 Pyrazolothiazole compound |
| 04/14/2011 | US20110086881 Crystalline forms of a dimethylphenyl compound |
| 04/14/2011 | US20110086880 Novel alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 04/14/2011 | US20110086879 Carboxamide compounds and their use as calpain inhibitors |
| 04/14/2011 | US20110086878 Treatments for Neuropathy |
| 04/14/2011 | US20110086877 Small Molecule Inhibitors of Botulinum Neurotoxins |
| 04/14/2011 | US20110086876 Stable sns-595 compositions and methods of preparation |
| 04/14/2011 | US20110086875 Powdered Medicament for Nasal Delivery of Ascorbic Acid for Reducing Apomorphine Induced Toxicity to Ciliated Tissue |
| 04/14/2011 | US20110086874 Methods of Converting a Patient's Treatment Regimen from Intravenous Administration of an Opioid to Oral Co-Administration of Morphine and Oxycodone Using a Dosing Algorithm to Provide Analgesia |
| 04/14/2011 | US20110086873 Methods of Converting a Patient's Treatment Regimen from Intravenous Administration of an Opioid to Oral Co-Administration of Morphine and Oxycodone Using a Dosing Algorithm to Provide Analgesia |
| 04/14/2011 | US20110086872 Berberine as a selective lung cancer agent and other compositions and methods |
| 04/14/2011 | US20110086871 Rifaximin compositions and method of use |
| 04/14/2011 | US20110086870 Combination Therapy |
| 04/14/2011 | US20110086869 Methods for treating viral disorders |
| 04/14/2011 | US20110086868 Specific inhibitors for vascular endothelial growth factor receptors |
| 04/14/2011 | US20110086867 6-(c2-6alkylseleno)purines and methods for treating neural measles viral infection therewith |
| 04/14/2011 | US20110086866 Inhibitors of bruton's tyrosine kinase |
| 04/14/2011 | US20110086865 Ant-ligands molecules and biological applications |
| 04/14/2011 | US20110086864 N-hydroxyamide derivatives and use thereof |
| 04/14/2011 | US20110086863 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 04/14/2011 | US20110086862 Polymorphs of pardoprunox |
| 04/14/2011 | US20110086861 Pharmaceutical compositions and methods for the treatment of cancer |
| 04/14/2011 | US20110086860 Compound |